{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:42:59Z","timestamp":1789850579819,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ajo.2013.12.027","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T14:16:34Z","timestamp":1389276994000},"page":"807-812.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Topical Rebamipide Treatment for Superior Limbic Keratoconjunctivitis in Patients With Thyroid Eye Disease"],"prefix":"10.1016","volume":"157","author":[{"given":"Yasuhiro","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajo.2013.12.027_bib1","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","article-title":"Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study","volume":"119","author":"Kinoshita","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2013.12.027_bib2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2013.12.027_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/IOP.0b013e3182833dee","article-title":"Anatomy of secretory glands in the eyelid and conjunctiva: a photographic review","volume":"29","author":"Takahashi","year":"2013","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.ajo.2013.12.027_bib4","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bjophthalmol-2012-302868","article-title":"Rebamipide increases barrier function and attenuates TNF\u03b1-induced barrier disruption and cytokine expression in human corneal epithelial cells","volume":"97","author":"Tanaka","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2013.12.027_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/jop.2011.0147","article-title":"Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits","volume":"28","author":"Urashima","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ajo.2013.12.027_bib6","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1167\/iovs.12-11294","article-title":"Protection of human corneal epithelial cells from TNF-\u03b1-induced disruption of barrier function by rebamipide","volume":"54","author":"Kimura","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 2","key":"10.1016\/j.ajo.2013.12.027_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/eye.1989.26","article-title":"Superior limbic keratoconjunctivitis (SLK)","volume":"3","author":"Nelson","year":"1989","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.ajo.2013.12.027_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/ICO.0b013e3181967006","article-title":"Treatment of superior limbic keratoconjunctivitis with a large-diameter contact lens and botulinum toxin A","volume":"28","author":"Kim","year":"2009","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2013.12.027_bib9","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0161-6420(95)30843-3","article-title":"Superior limbic keratoconjunctivitis: a prognostic sign for severe Grave's ophthalmopathy","volume":"102","author":"Kadrmas","year":"1995","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2013.12.027_bib10","first-page":"965","article-title":"Clinical study of superior limbic keratoconjunctivitis associated with dysthyroid ophthalmopathy [in Japanese]","volume":"54","author":"Nakashima","year":"2003","journal-title":"Folia Ophthalmol Jpn"},{"issue":"5","key":"10.1016\/j.ajo.2013.12.027_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archopht.1969.00990020582002","article-title":"Clinical features of superior limbic keratoconjunctivitis in Australia: a probable association with thyrotoxicosis","volume":"82","author":"Cher","year":"1969","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2013.12.027_bib12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0021-5155(01)00407-5","article-title":"Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy","volume":"45","author":"Murakami","year":"2001","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2013.12.027_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10384-008-0545-7","article-title":"Tear film osmolarity in patients with thyroid ophthalmopathy","volume":"52","author":"Iskeleli","year":"2008","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2013.12.027_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1755-3768.1983.tb01401.x","article-title":"Ocular surface drying and tear film osmolarity in thyroid eye disease","volume":"61","author":"Gilberd","year":"1983","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2013.12.027_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00003226-200111000-00006","article-title":"Treatment of superior limbic keratoconjunctivitis by application of autologous serum","volume":"20","author":"Goto","year":"2001","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2013.12.027_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ICO.0b013e318030d230","article-title":"Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis","volume":"26","author":"Shen","year":"2007","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajo.2013.12.027_bib17","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S0161-6420(03)00538-4","article-title":"Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis","volume":"110","author":"Perry","year":"2003","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2013.12.027_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/ICO.0b013e318033bd25","article-title":"Topical cyclosporine A in the treatment of superior limbic keratoconjunctivitis a long-term follow-up","volume":"27","author":"Sahin","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2013.12.027_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9394(14)71647-2","article-title":"Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis","volume":"124","author":"Yang","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2013.12.027_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9394(88)90245-0","article-title":"Vitamin A eyedrops for superior limbic keratoconjunctivitis","volume":"105","author":"Ohashi","year":"1988","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2013.12.027_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9394(02)01975-X","article-title":"New surgical treatment for superior limbic keratoconjunctivitis and its association with conjunctivochalasis","volume":"135","author":"Yokoi","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2013.12.027_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/ICO.0b013e3181d1d1cc","article-title":"Conjunctival resection with and without amniotic membrane graft for the treatment of superior limbic keratoconjunctivitis","volume":"29","author":"Gris","year":"2010","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2013.12.027_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajo.2007.10.025","article-title":"Conjunctival resection combined with Tenon layer excision and the involvement of mast cells in superior limbic keratoconjunctivitis","volume":"145","author":"Sun","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2013.12.027_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/ICO.0b013e31805771c6","article-title":"New surgical approach for superior conjunctivochalasis","volume":"26","author":"Kheirkhah","year":"2007","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2013.12.027_bib25","first-page":"341","article-title":"Further observations on superior limbic keratoconjunctivitis","volume":"71","author":"Theodore","year":"1967","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"issue":"3","key":"10.1016\/j.ajo.2013.12.027_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9394(14)72177-4","article-title":"Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis","volume":"120","author":"Grutzmacher","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2013.12.027_bib27","first-page":"129","article-title":"Treatment of superior limbic keratoconjunctivitis with topical cromolyn sodium","volume":"19","author":"Confine","year":"1987","journal-title":"Ann Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2013.12.027_bib28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00003226-200211000-00009","article-title":"Ketotifen fumarate treatment of superior limbic keratoconjunctivitis","volume":"21","author":"Udell","year":"2002","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ajo.2013.12.027_bib29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/ICO.0b013e318295e6b9","article-title":"Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment","volume":"32","author":"Kymionis","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2013.12.027_bib30","series-title":"Grave's Orbitopathy: A Multidisciplinary Approach","first-page":"66","article-title":"Diagnosis and differential diagnosis of Grave's orbitopathy","author":"Mourits","year":"2007"},{"issue":"1","key":"10.1016\/j.ajo.2013.12.027_bib31","first-page":"10","article-title":"Diagnostic tests in the sicca syndrome","volume":"82","author":"van Bijsterveld","year":"1969","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2013.12.027_bib32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archopht.121.11.1537","article-title":"A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability","volume":"121","author":"Miyata","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2013.12.027_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Grave's ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2013.12.027_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bjo.85.1.99","article-title":"Repeatability and reproducibility of upper eyelid measurements","volume":"85","author":"Boboridis","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2013.12.027_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.beem.2011.10.004","article-title":"Ethnic differences in the clinical presentation of Grave's ophthalmopathy","volume":"26","author":"Chng","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ajo.2013.12.027_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1043-2760(02)00622-7","article-title":"Grave's ophthalmopathy: a rational approach to treatment","volume":"13","author":"Wieringa","year":"2002","journal-title":"Trends Endocrinol Metab"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941400004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941400004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:09:37Z","timestamp":1757596177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293941400004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S000293941400004X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2013.12.027","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Rebamipide Treatment for Superior Limbic Keratoconjunctivitis in Patients With Thyroid Eye Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2013.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}